Implementation of antiretroviral therapy guidelines for under-five children in Tanzania: translating recommendations into practice

Paediatric antiretroviral therapy (ART) guidelines have been updated several times in recent years. We assessed implementation of ART guidelines among under‐five children to inform the transition to universal paediatric ART in Tanzania.

[1]  S. Rosen,et al.  Systematic review of retention of pediatric patients on HIV treatment in low and middle-income countries 2008–2013 , 2015, AIDS.

[2]  B. Chi,et al.  Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income Countries , 2015, Journal of acquired immune deficiency syndromes.

[3]  K. Moland,et al.  Challenges of disseminating clinical practice guidelines in a weak health system: the case of HIV and infant feeding recommendations in Tanzania , 2014, International Breastfeeding Journal.

[4]  J. Bartlett,et al.  Progress in the Prevention of Mother to Child Transmission of HIV in Three Regions of Tanzania: A Retrospective Analysis , 2014, PloS one.

[5]  B. Eley,et al.  Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late? , 2014, Journal of the International AIDS Society.

[6]  G. Antelman,et al.  Reviewing progress: 7 year trends in characteristics of adults and children enrolled at HIV care and treatment clinics in the United Republic of Tanzania , 2013, BMC Public Health.

[7]  M. Lemnge,et al.  Early infant diagnosis of HIV in three regions in Tanzania; successes and challenges , 2013, BMC Public Health.

[8]  E. Abrams,et al.  Decentralization of Pediatric HIV Care and Treatment in Five Sub-Saharan African Countries , 2013, Journal of acquired immune deficiency syndromes.

[9]  E. Abrams,et al.  Retention of HIV-Infected Children on Antiretroviral Treatment in HIV Care and Treatment Programs in Kenya, Mozambique, Rwanda, and Tanzania , 2013, Journal of acquired immune deficiency syndromes.

[10]  M. Egger,et al.  Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review , 2013, PloS one.

[11]  L. Fairlie,et al.  Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa , 2013, Global health action.

[12]  L. Fairlie,et al.  Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. , 2013, Global health action.

[13]  T. Ayele,et al.  Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: A retrospective follow up study , 2012, BMC Pediatrics.

[14]  A. Jaye,et al.  Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa , 2012, AIDS Research and Therapy.

[15]  C. Gilks,et al.  Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Maria H. Kim,et al.  Mortality and Clinical Outcomes in HIV-Infected Children on Antiretroviral Therapy in Malawi, Lesotho, and Swaziland , 2012, Pediatrics.

[17]  W. Moss,et al.  Risk Factors for Pre-Treatment Mortality among HIV-Infected Children in Rural Zambia: A Cohort Study , 2011, PloS one.

[18]  M. Yotebieng,et al.  Antiretroviral Therapy Responses Among Children Attending a Large Public Clinic in Soweto, South Africa , 2011, The Pediatric infectious disease journal.

[19]  S. Rahlenbeck,et al.  Outcome in a paediatric cohort receiving ART in Addis Abeba, Ethiopia , 2011, Acta paediatrica.

[20]  F. Dabis,et al.  12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008 , 2011, BMC Public Health.

[21]  F. Dabis,et al.  Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. , 2010, Bulletin of the World Health Organization.

[22]  Victoria Nankabirwa,et al.  Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania , 2010, BMC pediatrics.

[23]  M. Egger,et al.  Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. , 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[24]  F. Behets,et al.  Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility , 2008, BMC infectious diseases.

[25]  M. Kruger,et al.  Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. , 2007, Journal of tropical pediatrics.

[26]  B. Chi,et al.  Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. , 2007, JAMA.

[27]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[28]  Peter Piot,et al.  Joint United Nations Program on HIV/AIDS (UNAIDS) , 1997 .